OBJECTIVE: To assess long-term, cause-specific mortality rates and rate ratios of the patients alive at 1 year after subarachnoid hemorrhage (SAH). METHODS: The population-based, prospective, cohort study with a nested case-control design consisted of 64,349 persons (aged 25-74 years at enrollment) who participated in the National FINRISK Study between 1972 and 2007. Four hundred thirty-seven SAH cases, 233 one-year SAH survivors, and their matched intrinsic controls were identified and followed up until the end of 2009 through the nationwide Finnish Causes of Death Register. All-cause mortality rates and rate ratios of the 1-year SAH survivors and controls were the main outcome measures. RESULTS: Eighty-eight (37.8%) of 233 one-year SAH survivors died during the total follow-up time of 2,487 person-years (median 8.6 years, range 0.1-35.8 years). The 1-year SAH survivors had a hazard ratio of 1.96 (95% confidence interval 1.57-2.47) for death compared with the matched general population with 10 controls for each SAH survivor. One-year SAH survivors had up to 31 additional deaths per 1,000 person-years compared with controls with minimal cerebrovascular risk factors. The higher long-term risk of death among SAH survivors was attributed solely to cerebrovascular diseases, and most important modifiable risk factors for death were smoking, high systolic blood pressure (≥ 159 mm Hg), and high cholesterol levels (≥ 7.07 mmol/L). CONCLUSION: One-year SAH survivors have excess mortality, which is attributed to an exceptional risk of deadly cerebrovascular events. Aggressive post-SAH cerebrovascular risk factor intervention strategies are highly warranted.
OBJECTIVE: To assess long-term, cause-specific mortality rates and rate ratios of the patients alive at 1 year after subarachnoid hemorrhage (SAH). METHODS: The population-based, prospective, cohort study with a nested case-control design consisted of 64,349 persons (aged 25-74 years at enrollment) who participated in the National FINRISK Study between 1972 and 2007. Four hundred thirty-seven SAH cases, 233 one-year SAH survivors, and their matched intrinsic controls were identified and followed up until the end of 2009 through the nationwide Finnish Causes of Death Register. All-cause mortality rates and rate ratios of the 1-year SAH survivors and controls were the main outcome measures. RESULTS: Eighty-eight (37.8%) of 233 one-year SAH survivors died during the total follow-up time of 2,487 person-years (median 8.6 years, range 0.1-35.8 years). The 1-year SAH survivors had a hazard ratio of 1.96 (95% confidence interval 1.57-2.47) for death compared with the matched general population with 10 controls for each SAH survivor. One-year SAH survivors had up to 31 additional deaths per 1,000 person-years compared with controls with minimal cerebrovascular risk factors. The higher long-term risk of death among SAH survivors was attributed solely to cerebrovascular diseases, and most important modifiable risk factors for death were smoking, high systolic blood pressure (≥ 159 mm Hg), and high cholesterol levels (≥ 7.07 mmol/L). CONCLUSION: One-year SAH survivors have excess mortality, which is attributed to an exceptional risk of deadly cerebrovascular events. Aggressive post-SAH cerebrovascular risk factor intervention strategies are highly warranted.
Authors: Miikka Korja; Karri Silventoinen; Peter McCarron; Slobodan Zdravkovic; Axel Skytthe; Arto Haapanen; Ulf de Faire; Nancy L Pedersen; Kaare Christensen; Markku Koskenvuo; Jaakko Kaprio Journal: Stroke Date: 2010-09-16 Impact factor: 7.914
Authors: Erkki Vartiainen; Tiina Laatikainen; Markku Peltonen; Anne Juolevi; Satu Männistö; Jouko Sundvall; Pekka Jousilahti; Veikko Salomaa; Liisa Valsta; Pekka Puska Journal: Int J Epidemiol Date: 2009-12-03 Impact factor: 7.196
Authors: Andrew J Molyneux; Richard S C Kerr; Jacqueline Birks; Najib Ramzi; Julia Yarnold; Mary Sneade; Joan Rischmiller Journal: Lancet Neurol Date: 2009-03-28 Impact factor: 44.182
Authors: Annukka M Lahtinen; Peter A Noseworthy; Aki S Havulinna; Antti Jula; Pekka J Karhunen; Johannes Kettunen; Markus Perola; Kimmo Kontula; Christopher Newton-Cheh; Veikko Salomaa Journal: PLoS One Date: 2012-07-23 Impact factor: 3.240
Authors: Goodarz Danaei; Eric L Ding; Dariush Mozaffarian; Ben Taylor; Jürgen Rehm; Christopher J L Murray; Majid Ezzati Journal: PLoS Med Date: 2009-04-28 Impact factor: 11.069
Authors: Blessing N R Jaja; Daniel Attalla; R Loch Macdonald; Tom A Schweizer; Michael D Cusimano; Nima Etminan; Daniel Hanggi; David Hasan; S Claiborne Johnston; Peter Le Roux; Benjamin Lo; Ada Louffat-Olivares; Stephan Mayer; Andrew Molyneux; Adam Noble; Audrey Quinn; Thomas Schenk; Julian Spears; Jeffrey Singh; Michael Todd; James Torner; Ming Tseng; William van den Bergh; Mervyn D I Vergouwen; George K C Wong Journal: Neurocrit Care Date: 2014-12 Impact factor: 3.210
Authors: Philippe Bijlenga; Akio Morita; Nerissa U Ko; J Mocco; Sandrine Morel; Yuichi Murayama; Marieke J H Wermer; Robert D Brown Journal: Neurocrit Care Date: 2019-06 Impact factor: 3.210
Authors: Tanyeri Barak; Emma Ristori; A Gulhan Ercan-Sencicek; Danielle F Miyagishima; Carol Nelson-Williams; Weilai Dong; Sheng Chih Jin; Andrew Prendergast; William Armero; Octavian Henegariu; E Zeynep Erson-Omay; Akdes Serin Harmancı; Mikhael Guy; Batur Gültekin; Deniz Kilic; Devendra K Rai; Nükte Goc; Stephanie Marie Aguilera; Burcu Gülez; Selin Altinok; Kent Ozcan; Yanki Yarman; Süleyman Coskun; Emily Sempou; Engin Deniz; Jared Hintzen; Andrew Cox; Elena Fomchenko; Su Woong Jung; Ali Kemal Ozturk; Angeliki Louvi; Kaya Bilgüvar; E Sander Connolly; Mustafa K Khokha; Kristopher T Kahle; Katsuhito Yasuno; Richard P Lifton; Ketu Mishra-Gorur; Stefania Nicoli; Murat Günel Journal: Nat Med Date: 2021-12-09 Impact factor: 87.241
Authors: Nefize Turan; Robert Allen-James Heider; Dobromira Zaharieva; Faiz U Ahmad; Daniel L Barrow; Gustavo Pradilla Journal: Transl Stroke Res Date: 2015-11-16 Impact factor: 6.829
Authors: Vivien H Lee; Bichun Ouyang; Sayona John; James J Conners; Rajeev Garg; Thomas P Bleck; Richard E Temes; Shawna Cutting; Shyam Prabhakaran Journal: Neurocrit Care Date: 2014-08 Impact factor: 3.210
Authors: Miikka Korja; Karri Silventoinen; Tiina Laatikainen; Pekka Jousilahti; Veikko Salomaa; Juha Hernesniemi; Jaakko Kaprio Journal: PLoS One Date: 2013-09-09 Impact factor: 3.240
Authors: Miikka Korja; Lena M Thorn; Stefanie Hägg; Jukka Putaala; Ron Liebkind; Valma Harjutsalo; Carol M Forsblom; Daniel Gordin; Turgut Tatlisumak; Per-Henrik Groop Journal: Diabetes Care Date: 2013-07-22 Impact factor: 19.112